Cook Pharmica LLC, the contract biopharmaceutical manufacturing division of Cook Group, Inc. is halfway to its initial employment goal of 200 well ahead of schedule. Aug. 7, 2006 marks the start date of Cook Pharmica's 100th employee at its high-tech Bloomington manufacturing facility.
"We are ahead of schedule in our hiring projections and have been very fortunate in attracting talent with strong educational credentials and experience in the biotech industry," says Jerry Arthur, president of Cook Pharmica LLC. "Cook Pharmica is proud to have honored its commitment to the community by providing job opportunities for the local talent pool."
More employment success is expected through Cook's community partnership in a recent $1.25M Strategic Skills Initiative grant from Governor Mitch Daniels and the Indiana Department of Workforce Development for the establishment of the Indiana Life Sciences Education and Training Institute. Located in Monroe County, the Institute will provide skills training for high-wage, high-growth life sciences jobs in the region.
"We are very encouraged by the complimentary feedback our employees have received during client visits and other industry interaction. These employees will play an integral role in the promising future of Cook Pharmica," adds Arthur.
About Cook Pharmica
Cook (www.cookmedical.com) is the world's largest privately held manufacturer of medical devices, with international headquarters in Bloomington, Ind. Since its founding in 1963, Cook has created innovative technologies for drug-eluting and bare metal stents, aortic and vascular endografts, catheters, wire guides, introducer needles and sheaths, embolization coils, medical biomaterials and contract manufacturing of biopharmaceuticals, vena cava filters and other minimally invasive medical devices for radiology, cardiology, urology and OB/GYN, critical care medicine, surgery, gastroenterology, bone access and endovascular therapies.
Cook Pharmica LLC (www.cookpharmica.com), in cooperation with the Bloomington Economic Development Corporation, local and state government agencies, and major research universities in the state, has constructed a state-of-the-art biotech drug contract manufacturing facility. Using mammalian cell fermentation, the company grows batches of cells genetically engineered to produce biopharmaceutical products used in biotech bulk drugs, clinical trials and small-scale production runs for commercial products.
For information on employment and other Human Resources issues, visit www.cookpharmica.com/contact_us/hr.htm
